Navigating the research–clinical interface in genomic medicine: analysis from the CSER Consortium

[1]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[2]  Nikhil Wagle,et al.  Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. , 2016, American journal of human genetics.

[3]  Mildred K Cho,et al.  Adrift in the gray zone: IRB perspectives on research in the learning health system , 2016, AJOB empirical bioethics.

[4]  G. Marchant,et al.  Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study , 2016, Journal of Law, Medicine & Ethics.

[5]  W. Burke,et al.  Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide , 2015, Journal of Law, Medicine & Ethics.

[6]  M. Angrist,et al.  Living laboratory: whole‐genome sequencing as a learning healthcare enterprise , 2015, Clinical genetics.

[7]  M. Dorschner,et al.  Regulatory changes raise troubling questions for genomic testing , 2014, Genetics in Medicine.

[8]  B. Knoppers,et al.  The Challenge of Informed Consent and Return of Results in Translational Genomics: Empirical Analysis and Recommendations , 2014, Journal of Law, Medicine & Ethics.

[9]  S. Hull,et al.  The unintended implications of blurring the line between research and clinical care in a genomic age. , 2014, Personalized medicine.

[10]  Heidi L Rehm,et al.  Return of genomic results to research participants: the floor, the ceiling, and the choices in between. , 2014, American journal of human genetics.

[11]  Gail P Jarvik,et al.  Return of results: Ethical and legal distinctions between research and clinical care , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[12]  S. Daack-Hirsch,et al.  The role of patient engagement in personalized healthcare. , 2014, Personalized medicine.

[13]  Robert C. Green,et al.  Guidelines for return of research results from pediatric genomic studies: deliberations of the Boston Children’s Hospital Gene Partnership Informed Cohort Oversight Board , 2014, Genetics in Medicine.

[14]  Robert C. Green,et al.  Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium , 2013, Genetics in Medicine.

[15]  Susan M Wolf,et al.  Return of individual research results and incidental findings: facing the challenges of translational science. , 2013, Annual review of genomics and human genetics.

[16]  F. Miller,et al.  The research-clinical practice distinction, learning health systems, and relationships. , 2013, The Hastings Center report.

[17]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[18]  L. Biesecker.  Incidental variants are critical for genomics. , 2013, American journal of human genetics.

[19]  Dan M. Roden,et al.  Implementing genomic medicine in the clinic: the future is here , 2013, Genetics in Medicine.

[20]  Muin J. Khoury,et al.  The arrival of genomic medicine to the clinic is only the beginning of the journey , 2013, Genetics in Medicine.

[21]  Steven N Goodman,et al.  An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics. , 2013, The Hastings Center report.

[22]  S. Fullerton,et al.  Values in Translation: How Asking the Right Questions Can Move Translational Science Toward Greater Health Impact , 2012, Clinical and translational science.

[23]  A. Guttmacher,et al.  Realizing genomic medicine. , 2012, The New England journal of medicine.

[24]  T. Beauchamp,et al.  The historical foundations of the research-practice distinction in bioethics , 2012, Theoretical medicine and bioethics.

[25]  S. Joffe,et al.  Can Research and Care Be Ethically Integrated? , 2011, The Hastings Center report.

[26]  C. Grady,et al.  Clinical Trials and Medical Care: Defining the Therapeutic Misconception , 2007, PLoS medicine.

[27]  Kenneth D. Mandl,et al.  Reestablishing the Researcher-Patient Compact , 2007, Science.

[28]  G. Henderson,et al.  The many meanings of care in clinical research. , 2006, Sociology of health & illness.

[29]  H. Richardson,et al.  The ancillary-care responsibilities of medical researchers. An ethical framework for thinking about the clinical care that researchers owe their subjects. , 2004, The Hastings Center report.

[30]  Roger Anderson,et al.  Homeland Security , 2004, Gov. Inf. Q..

[31]  J. P. Porter.  The federal policy for the protection of human subjects. , 1991, IRB.

[32]  W. Raub.  From the National Institutes of Health. , 1990, JAMA.

[33]  David W. Louisell,et al.  National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: Research on the Fetus , 1976 .